Strategic application domain: MedTech
Application market: Ophthalmology
Type of activity: Medical device
Technologies: Ultrasound
Presbyopia is the loss of accommodation affecting any individual after the age of 45 and preventing close reading. Although its consequences have been known and corrected by converging glasses since antiquity, biological aging, which modifies the biomechanics of the lens and makes it lose its flexibility, has only recently been understood.
To date, no one has developed a treatment that restores the natural biomechanical properties of the aging crystalline lens. The expertise in focused ultrasound applied to ophthalmology is a very strong point of our territory. Also, by bringing together 2 laboratories and 2 industrial partners with major scientific expertise in ophthalmology, ultrasound, cell biology, biochemistry, optics, biomechanics and engineering, we are equipped to meet this ambitious challenge through PRESB-INNOV-US: moving towards a radical paradigm shift to overcome (finally)presbyopia.
ANR
ANR Générique
PRCE
2021
national project
On going
Duration: 36 months
Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.